EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68

Xuran Zhang, Kyo Chul Lee, Joon Young Choi, Kyung-Han Lee, Yearn Seong Choe iD

Molecular Pharmaceutics · 03.02.2025 · 22 (2) · 906-917

DOI: 10.1021/acs.molpharmaceut.4c01080 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Molecular Pharmaceutics, online erschienen am 30.12.2024. Verfasst von Xuran Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Fluorine Radioisotopes, Radiopharmaceuticals, Copper Radioisotopes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast activation protein inhibitors (FAPIs) labeled with gallium-68 and lutetium-177 show potential for use in the diagnosis and treatment of various cancers expressing FAP. However, 177Lu-labeled FAPIs often exhibit short tumor retention time, limiting their therapeutic applications. To improve tumor retention, we synthesized three radiolabeled dimeric FAPIs, [18F]1, [64Cu]2, and [68Ga]3. These were prepared by chelating Al[18F]F to 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-l-glutamic acid (E)-(FAPI)2 and copper-64 or gallium-68 to 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-E-(FAPI)2. NOTA-E-(FAPI)2 and DOTA-E-(FAPI)2 showed higher binding affinities for FAP compared with that of FAPI-04 (IC50 = 0.47 and 0.16 nM vs 0.89 nM, respectively). All radioligands were synthesized in high decay-corrected radiochemical yields (59-96%) and were stable in fetal bovine serum and phosphate-buffered saline. The more hydrophilic radioligand, [68Ga]3, was selected for cellular uptake studies, which confirmed FAP-specific uptake. Positron emission tomography imaging and ex vivo biodistribution studies in U87MG tumor-bearing mice revealed high tumor uptake of all three radioligands, with significant blocking observed after preinjection of FAPI-04. [64Cu]2 and [68Ga]3 exhibited favorable in vivo pharmacokinetics compared to those of [18F]1. Notably, [68Ga]3 showed lower normal organ uptake than did the other two radioligands, and moreover, it exhibited higher, more prolonged tumor uptake than its monomeric counterpart [68Ga]Ga-FAPI-04 over a 3 h period, suggesting its potential as a promising FAP-specific theranostic radioligand.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesFluorine RadioisotopesRadiopharmaceuticalsCopper RadioisotopesMembrane ProteinsGelatinasesSerine EndopeptidasesAnimalsMiceHumansTissue DistributionCell Line, TumorPositron-Emission TomographyFemaleLigandsLutetiumMice, NudeEndopeptidasesRadioisotopesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

PETcopper-64dimerfibroblast activation protein (FAP)fluorine-18gallium-68

Substanzen

Gallium RadioisotopesFluorine RadioisotopesRadiopharmaceuticalsCopper RadioisotopesMembrane ProteinsLigandsLutetiumGelatinasesSerine EndopeptidasesEndopeptidases

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
  • Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.
  • Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea.

ORCID-Profile: Yearn Seong Choe

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Zhang, X., Lee, K. C., Choi, J. Y., Lee, K. H., & Choe, Y. S. (2025). Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68. Molecular Pharmaceutics, 22(2), 906-917. https://doi.org/10.1021/acs.molpharmaceut.4c01080

Vancouver

Zhang X, Lee KC, Choi JY, Lee KH, Choe YS. Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68. Molecular Pharmaceutics. 2025;22(2):906-917. doi:10.1021/acs.molpharmaceut.4c01080

BibTeX
@article{Zhang2025,
  author = {Zhang, Xuran and Lee, Kyo Chul and Choi, Joon Young and Lee, Kyung-Han and Choe, Yearn Seong},
  title = {Comparative Study of Dimeric Fibroblast Activation Protein-Targeting Radioligands Labeled with Fluorine-18, Copper-64, and Gallium-68},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {2},
  pages = {906--917},
  doi = {10.1021/acs.molpharmaceut.4c01080}
}
Kostenlos starten →